These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. More about cellular signaling by antiphospholipid antibodies. Lackner KJ J Thromb Haemost; 2015 Oct; 13(10):1925-7. PubMed ID: 26302892 [No Abstract] [Full Text] [Related]
26. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. Nash MJ; Camilleri RS; Kunka S; Mackie IJ; Machin SJ; Cohen H J Thromb Haemost; 2004 Jul; 2(7):1077-81. PubMed ID: 15219190 [TBL] [Abstract][Full Text] [Related]
27. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Motta M; Chirico G; Rebaioli CB; Faden D; Lojacono A; Allegri F; Migliori C; Tincani A Am J Perinatol; 2006 May; 23(4):247-51. PubMed ID: 16625500 [TBL] [Abstract][Full Text] [Related]
28. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? Asherson RA; Shoenfeld Y J Rheumatol; 2000 Jan; 27(1):12-4. PubMed ID: 10648011 [No Abstract] [Full Text] [Related]
29. High-avidity anti-beta glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-beta glycoprotein I antibodies. de Laat B; Derksen RH; de Groot PG J Thromb Haemost; 2006 Jul; 4(7):1619-21. PubMed ID: 16839363 [No Abstract] [Full Text] [Related]
30. Anti-beta 2-glycoprotein I antibodies do not increase TF activity by de-encryption. Wolberg AS; Roubey RA Thromb Res; 2004; 114(1):67-71. PubMed ID: 15262487 [No Abstract] [Full Text] [Related]
31. Platelets and the antiphospholipid syndrome. Urbanus RT; Derksen RH; de Groot PG Lupus; 2008 Oct; 17(10):888-94. PubMed ID: 18827053 [TBL] [Abstract][Full Text] [Related]
32. Sulfatides: targets for anti-phospholipid antibodies. Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197 [TBL] [Abstract][Full Text] [Related]
33. Anti-beta2-glycoprotein I antibody testing in the laboratory diagnosis of antiphospholipid syndrome. Pengo V J Thromb Haemost; 2005 Jun; 3(6):1158-9. PubMed ID: 15946203 [No Abstract] [Full Text] [Related]
34. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Meroni PL; Raschi E; Testoni C; Parisio A; Borghi MO Autoimmun Rev; 2004 Nov; 3(7-8):510-5. PubMed ID: 15546799 [TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance. Sanna G; Bertolaccini ML; Mameli A; Hughes GR; Khamashta MA; Mathieu A Ann Rheum Dis; 2005 Dec; 64(12):1795-6. PubMed ID: 16284349 [No Abstract] [Full Text] [Related]
36. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048 [TBL] [Abstract][Full Text] [Related]
37. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Robertson SA; Roberts CT; van Beijering E; Pensa K; Sheng Y; Shi T; Krilis SA Mol Hum Reprod; 2004 Jun; 10(6):409-16. PubMed ID: 15100383 [TBL] [Abstract][Full Text] [Related]
38. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. Kajiwara T; Yasuda T; Matsuura E J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950 [TBL] [Abstract][Full Text] [Related]
39. Laboratory evaluation of the antiphospholipid syndrome. Abo SM; DeBari VA Ann Clin Lab Sci; 2007; 37(1):3-14. PubMed ID: 17311864 [TBL] [Abstract][Full Text] [Related]